Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme
Provides structured US market access for EvoLiver FDA-designated liver cancer [...]
Provides structured US market access for EvoLiver FDA-designated liver cancer [...]
Featuring keynotes from: Steve Bates, Executive Chair at the Office [...]
SPT Labtech to develop an automated sample preparation platform for [...]
Aurase Wound Gel shows 22x faster debridement and 7x faster [...]
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead [...]
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and [...]
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal [...]
Partnership will deliver AI-guided end-to-end workflow to access challenging membrane [...]
Enhancing patient treatment experience and care with a new self-administered [...]
Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for [...]